# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-19-003045
Filing Date
2019-01-07
Accepted
2019-01-07 06:31:11
Documents
22
Period of Report
2019-01-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d678791d8k.htm | 8-K | 15522
2 | EX-99.1 | d678791dex991.htm | EX-99.1 | 20383
3 | GRAPHIC | g678791ex99_1s10g1.jpg | GRAPHIC | 389698
4 | GRAPHIC | g678791ex99_1s11g1.jpg | GRAPHIC | 248296
5 | GRAPHIC | g678791ex99_1s12g1.jpg | GRAPHIC | 278163
6 | GRAPHIC | g678791ex99_1s13g1.jpg | GRAPHIC | 344763
7 | GRAPHIC | g678791ex99_1s14g1.jpg | GRAPHIC | 245593
8 | GRAPHIC | g678791ex99_1s15g1.jpg | GRAPHIC | 386368
9 | GRAPHIC | g678791ex99_1s16g1.jpg | GRAPHIC | 249929
10 | GRAPHIC | g678791ex99_1s17g1.jpg | GRAPHIC | 433351
11 | GRAPHIC | g678791ex99_1s18g1.jpg | GRAPHIC | 310577
12 | GRAPHIC | g678791ex99_1s19g1.jpg | GRAPHIC | 283258
13 | GRAPHIC | g678791ex99_1s1g1.jpg | GRAPHIC | 175926
14 | GRAPHIC | g678791ex99_1s20g1.jpg | GRAPHIC | 284935
15 | GRAPHIC | g678791ex99_1s2g1.jpg | GRAPHIC | 679803
16 | GRAPHIC | g678791ex99_1s3g1.jpg | GRAPHIC | 243153
17 | GRAPHIC | g678791ex99_1s4g1.jpg | GRAPHIC | 503696
18 | GRAPHIC | g678791ex99_1s5g1.jpg | GRAPHIC | 369146
19 | GRAPHIC | g678791ex99_1s6g1.jpg | GRAPHIC | 290348
20 | GRAPHIC | g678791ex99_1s7g1.jpg | GRAPHIC | 348309
21 | GRAPHIC | g678791ex99_1s8g1.jpg | GRAPHIC | 312594
22 | GRAPHIC | g678791ex99_1s9g1.jpg | GRAPHIC | 424594
| Complete submission text file | 0001193125-19-003045.txt |  | 9408722

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36485 | Film No.: 19512120
SIC: 2834 Pharmaceutical Preparations